Invention Grant
- Patent Title: Methods of reducing the risk of experiencing a cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered a qualifying CV event
-
Application No.: US15483619Application Date: 2017-04-10
-
Publication No.: US10975145B2Publication Date: 2021-04-13
- Inventor: Tom Thuren , Andrew Zalewski , Michael Shetzline
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Meghan S. Adams
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/00
Abstract:
The present invention relates to an IL-1β binding antibody or a functional fragment thereof for use in preventing or reducing risk of experiencing a recurrent cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered of a qualifying CV event.
Public/Granted literature
- US20170275358A1 Use of IL-1ß Binding Antibodies Public/Granted day:2017-09-28
Information query
